ASLAN Pharmaceuticals Ltd (ASLN)
0.4025
-0.01
(-2.35%)
USD |
NASDAQ |
May 08, 16:00
0.4025
0.00 (0.00%)
After-Hours: 20:00
ASLAN Pharmaceuticals Shareholders Equity (Quarterly): -13.29M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.29M |
| September 30, 2023 | -0.8817M |
| June 30, 2023 | 6.371M |
| March 31, 2023 | 9.890M |
| December 31, 2022 | 8.365M |
| September 30, 2022 | 22.06M |
| June 30, 2022 | 32.67M |
| March 31, 2022 | 45.08M |
| December 31, 2021 | 57.30M |
| September 30, 2021 | 67.90M |
| June 30, 2021 | 75.35M |
| March 31, 2021 | 81.12M |
| December 31, 2020 | -10.45M |
| September 30, 2020 | -12.04M |
| Date | Value |
|---|---|
| June 30, 2020 | -8.758M |
| March 31, 2020 | -4.759M |
| December 31, 2019 | -1.677M |
| September 30, 2019 | 13.19M |
| June 30, 2019 | 18.42M |
| December 31, 2018 | 30.62M |
| September 30, 2018 | 41.77M |
| June 30, 2018 | 52.61M |
| March 31, 2018 | 26.96M |
| December 31, 2017 | 35.51M |
| September 30, 2017 | 49.78M |
| June 30, 2017 | 57.79M |
| March 31, 2017 | 33.67M |
| December 31, 2016 | 41.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.29M
Minimum
Dec 2023
81.12M
Maximum
Mar 2021
20.31M
Average
9.890M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 3.388B |
| Concord Medical Services Holdings Ltd | -299.35M |
| WAVE Life Sciences Ltd | 39.63M |
| Zai Lab Ltd | 796.12M |
| CytoMed Therapeutics Ltd | 8.514M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.63M |
| Total Liabilities (Quarterly) | 37.91M |